Corvus Pharmaceuticals, Inc.
DE ˙ DB ˙ US2210151005
10,25 € ↑0,31 (3,12%)
2026-06-04
DEL PRIS
SecurityDE:C17 / Corvus Pharmaceuticals, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership506,104 shares
Latest Disclosed Value $ 7,404,301
Northern Trust Corp reports 17.76% increase in ownership of C17 / Corvus Pharmaceuticals, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 506,104 shares of Corvus Pharmaceuticals, Inc. (DE:C17) valued at $5,739,219 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 429,771 shares of Corvus Pharmaceuticals, Inc.. This represents a change in shares of 17.76% during the quarter. The current value of the position is $5,187,566 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 506,104 76,333 17.76 7,404 123.75 0.0002
2026-02-17 2025-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 429,771 -36,715 -7.87 3,309 -3.75 0.0004
2025-11-14 2025-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 466,486 63,337 15.71 3,438 113.28 0.0004
2025-08-13 2025-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 403,149 293,853 268.86 1,613 364.55 0.0002
2025-05-13 2025-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 109,296 3,283 3.10 348 -38.80 0.0001
2025-02-14 2024-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 106,013 563 0.53 567 1.98 0.0001
2024-11-13 2024-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 105,450 22,460 27.06 557 268.21 0.0001
2024-08-14 2024-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 82,990 18,041 27.78 151 31.30 0.0000
2024-05-14 2024-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 64,949 -68 -0.10 116 0.88 0.0000
2024-02-13 2023-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 65,017 0 0.00 114 21.28 0.0000
2023-11-13 2023-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 65,017 0 0.00 95 -36.49 0.0000
2023-08-11 2023-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 65,017 3,349 5.43 149 164.29 0.0000
2023-05-15 2023-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 61,668 0 0.00 56 7.69 0.0000
2023-02-13 2022-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 61,668 9,442 18.08 52 20.93 0.0000
2022-11-14 2022-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 52,226 0 0.00 43 -17.31 0.0000
2022-08-12 2022-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 52,226 0 0.00 52 -39.53 0.0000
2022-05-13 2022-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 52,226 0 0.00 86 -31.75 0.0000
2022-02-08 2021-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 52,226 -7,036 -11.87 126 -56.10 0.0000
2021-11-15 2021-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 59,262 0 0.00 287 81.65 0.0001
2021-08-13 2021-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 59,262 21,384 56.45 158 36.21 0.0000
2021-05-12 2021-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 37,878 8,433 28.64 116 10.48 0.0000
2021-02-11 2020-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 29,445 0 0.00 105 -11.02 0.0000
2020-11-16 2020-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 29,445 2,535 9.42 118 61.64 0.0000
2020-08-14 2020-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 26,910 0 0.00 73 28.07 0.0000
2020-05-14 2020-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 26,910 0 0.00 57 -60.96 0.0000
2020-02-14 2019-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 26,910 -336 -1.23 146 78.05 0.0000
2019-11-13 2019-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 27,246 -114,471 -80.77 82 -84.53 0.0000
2019-08-13 2019-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 141,717 -9,071 -6.02 530 -12.54 0.0001
2019-05-13 2019-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 150,788 -554 -0.37 606 9.19 0.0001
2019-02-12 2018-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 151,342 -200 -0.13 555 -57.31 0.0002
2018-11-14 2018-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 151,542 1,696 1.13 1,300 -20.97 0.0003
2018-09-18 2018-06-30 13F/A-1 CORVUS PHARMACEUTICALS COM 221015100 149,846 61,276 69.18 1,645 61.12 0.0004
2018-08-14 2018-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 149,846 61,276 1,645
2018-05-09 2018-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 88,570 944 1.08 1,021 12.44 0.0003
2018-02-14 2017-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 87,626 -1,823 -2.04 908 -36.28 0.0002
2017-11-13 2017-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 89,449 2,924 3.38 1,425 36.10 0.0004
2017-08-11 2017-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 86,525 42,739 97.61 1,047 15.05 0.0003
2017-05-12 2017-03-31 13F CORVUS PHARMACEUTICALS COM 221015100 43,786 5,792 15.24 910 67.59 0.0003
2017-02-13 2016-12-31 13F CORVUS PHARMACEUTICALS COM 221015100 37,994 3,027 8.66 543 -5.57 0.0002
2016-11-09 2016-09-30 13F CORVUS PHARMACEUTICALS COM 221015100 34,967 3,440 10.91 575 27.78 0.0002
2016-08-12 2016-06-30 13F CORVUS PHARMACEUTICALS COM 221015100 31,527 31,527 450 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.